Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases
Conditions
- NSCLC (Advanced Non-small Cell Lung Cancer)
- EGFR Gene Mutations
- Brain Metastasis
Interventions
- DRUG: sac-TMT plus EGFR-TKI
Sponsor
Zhejiang Cancer Hospital
Collaborators